NASHVILLE TN--(Marketwire - Nov 14, 2011) - DHS Holding Co. "the company" (PINKSHEETS: [ DHSM ]) dedicated to improving the eBusiness infrastructure of the healthcare industry announced today that it will enter into preliminary talks with Radient Pharmaceuticals Corporation, Tustin Ca. a developer and marketer of In Vitro Diagnostic (IVD) cancer tests.

Gordon Getz CEO and Chairman of the Board of DHS Holding Co. announced the purpose of the talks with Radient Pharmaceuticals Corporation will be to discuss business opportunities that will benefit both organizations. DHS Holding Co. foresees a bright future for both itself and Radient Pharmaceutical Corporation Inc.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: the Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; inability to manage growth; and changes in government regulations, controls and similar matters. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes," "expects," "anticipates," "intends," "estimates," "plans," "projects," "should," or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise.